MapLight Therapeutics, Inc. (MPLT) vs Senseonics Holdings, Inc. (SENS)
A side-by-side comparison of MapLight Therapeutics, Inc. and Senseonics Holdings, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
MPLT
MapLight Therapeutics, Inc.
$9.69HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
SENS
Senseonics Holdings, Inc.
$9.96HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
Total return — MPLT vs SENS
growth of $100 · dividends reinvested · last 1yMPLT -49.4% (-49.4%/yr)SENS +38.6% (+38.6%/yr)SENS compounded faster over this window
MPLT SENS
MPLT vs SENS: by the numbers
- •SENS is the larger company ($416M vs $411M market cap).
- •Both run net losses; MPLT's is the smaller (0.00% vs -225.34% net margin).
Metrics side by side
Valuation
| Metric | MPLT | SENS |
|---|---|---|
| P/S ratio | N/A | 8.57 |
| P/B ratio | 1.18 | 4.61 |
Profitability
| Metric | MPLT | SENS |
|---|---|---|
| Gross margin | 0.00% | 44.71% |
| Operating margin | 0.00% | -193.83% |
| Net margin | 0.00% | -225.34% |
| ROE | -65.99% | -121.12% |
| ROIC | -69.35% | -71.22% |
Growth (annualized)
| Metric | MPLT | SENS |
|---|---|---|
| Revenue CAGR (5Y) | N/A | 35.10% |
| Total return CAGR (5Y) | N/A | -30.89% |
Go deeper
Dig into the metrics
MapLight Therapeutics ROESenseonics ROEMapLight Therapeutics operating marginSenseonics operating marginMapLight Therapeutics revenue growthSenseonics revenue growthMapLight Therapeutics free cash flowSenseonics free cash flow
MapLight Therapeutics & Senseonics appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.